MediWound Ltd.
MDWD
$15.90
$0.825.44%
Weiss Ratings | MDWD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | E | |||
Rating Factors | MDWD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Weak | |||
Efficiency Index | Very Weak | |||
Solvency Index | Good | |||
Total Return Index | Fair | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | MDWD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.79 | |||
Price History | MDWD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -0.31% | |||
30-Day Total Return | -4.73% | |||
60-Day Total Return | -4.90% | |||
90-Day Total Return | -8.25% | |||
Year to Date Total Return | -11.67% | |||
1-Year Total Return | 6.00% | |||
2-Year Total Return | 24.71% | |||
3-Year Total Return | 3.72% | |||
5-Year Total Return | 47.50% | |||
52-Week High % Change | -37.17% | |||
52-Week Low % Change | 18.00% | |||
Price | MDWD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $24.00 | |||
52-Week Low Price | $12.78 | |||
52-Week Low Price (Date) | Jun 21, 2024 | |||
52-Week High Price (Date) | Jul 05, 2024 | |||
Valuation | MDWD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 162.98M | |||
Enterprise Value | 126.75M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -1.04 | |||
Earnings Per Share Growth | 35.64% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 14.93 | |||
Price/Book (Q) | 5.22 | |||
Enterprise Value/Revenue (TTM) | 11.63 | |||
Price | $15.90 | |||
Enterprise Value/EBITDA (TTM) | -12.65 | |||
Enterprise Value/EBIT | -11.97 | |||
Market Cap Category | Micro Cap | |||
Dividends and Shares | MDWD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 10.79M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | MDWD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 972 7 797 14100 | |||
Address | -- | |||
Website | www.mediwound.com | |||
Country | Israel | |||
Year Founded | 2000 | |||
Profitability | MDWD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -- | |||
Profit Margin | -- | |||
Management Effectiveness | MDWD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -- | |||
Return on Equity | -- | |||
Income Statement | MDWD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | -- | |||
Total Revenue (TTM) | -- | |||
Revenue Per Share | $1.01 | |||
Gross Profit (TTM) | -- | |||
EBITDA (TTM) | -- | |||
EBIT (TTM) | -- | |||
Net Income (TTM) | -- | |||
Net Income Avl. to Common (TTM) | -- | |||
Total Revenue Growth (Q YOY) | 9.40% | |||
Earnings Growth (Q YOY) | -124.21% | |||
EPS Diluted (TTM) | -- | |||
EPS Diluted Growth (Q YOY) | -91.64% | |||
Balance Sheet | MDWD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 43.16M | |||
Cash Per Share (Q) | $4.00 | |||
Total Current Assets (Q) | 52.16M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 31.15M | |||
Current Ratio (Q) | 1.965 | |||
Book Value Per Share (Q) | $2.89 | |||
Total Assets (Q) | 73.50M | |||
Total Current Liabilities (Q) | 26.54M | |||
Total Debt (Q) | 6.93M | |||
Total Liabilities (Q) | 42.34M | |||
Total Common Equity (Q) | 31.15M | |||
Cash Flow | MDWD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -- | |||
Cash from Financing (TTM) | -- | |||
Net Change in Cash (TTM) | -- | |||
Levered Free Cash Flow (TTM) | -- | |||
Cash from Operations (TTM) | -- | |||